Tarrytown, NY, United States of America

Evan Koufos

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Evan Koufos

Introduction

Evan Koufos is an accomplished inventor based in Tarrytown, NY. He has made significant contributions to the field of biotechnology, particularly in the characterization and purification of proteins. His work is instrumental in advancing medical research and therapeutic development.

Latest Patents

Evan Koufos holds a patent titled "Methods of Characterizing and Purifying VEGF Receptor Fusion Protein." This patent reflects his expertise in biochemistry and his commitment to improving therapeutic proteins used in various medical applications. He has 1 patent to his name, showcasing his innovative approach to solving complex scientific challenges.

Career Highlights

Koufos is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing medicines for serious diseases. His role at Regeneron allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Throughout his career, Evan has worked alongside notable colleagues such as Paul Conroy and John Crowley. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Evan Koufos exemplifies the spirit of innovation in biotechnology through his patent and work at Regeneron Pharmaceuticals. His contributions are vital to the ongoing development of effective medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…